As Europe resumes AstraZeneca jabs, the pause has come at a cost 1616146381-ASTRAZENECA VACCINE 2

1616146381-ASTRAZENECA VACCINE 2

FILE -- Laboratory workers test the Astrazeneca vaccine in Oxford, England, Nov. 20, 2020. The European Union’s drug regulator said on March 18 that the AstraZeneca vaccine was safe and effective, a finding that officials hope will alleviate concerns about possible rare side effects involving blood clots. (Andrew Testa/The New York Times)
Share
Twitter Facebook Reddit Pinterest Email